Dermal matrix remodeling after nonablative laser therapy - 21/08/11
Ann Arbor, Michigan
Abstract |
Objective |
Nonablative laser therapy is widely practiced for cutaneous rejuvenation. We sought to quantify dermal molecular changes after exposure of photodamaged skin to nonablative laser energy.
Methods |
Nonablative laser therapy of forearm skin using either a 585-nm wavelength pulsed dye laser or a 1320-nm wavelength neodymium:yttrium-aluminum-garnet laser was performed. Serial biopsy specimens were obtained at baseline and various times after treatment.
Results |
Statistically significant increases in type I procollagen messenger RNA expression occurred after exposure of photodamaged skin to each laser. Induction was 47% (P < .05) and 84% (P < .05) above baseline levels 1 week after laser therapy among those treated with the pulsed dye and neodymium:yttrium-aluminum-garnet lasers, respectively. Substantial induction of type III procollagen, various matrix metalloproteinases, and primary cytokines was also demonstrated. Responses with respect to all molecules studied were highly variable.
Limitations |
This study addresses molecular changes after a single laser exposure whereas clinically, serial treatments are often provided.
Conclusions |
Nonablative laser therapy may result in quantifiable alterations in molecules associated with remodeling of the dermal matrix, although responses vary greatly among patients.
Le texte complet de cet article est disponible en PDF.Plan
Supported in part by the University of Michigan Department of Dermatology Laser Research Fund. ICN Pharmaceuticals Inc donated the NLite and CoolTouch lasers. During the course of this study, ICN Pharmaceuticals Inc divested itself of its Photonics subsidiary, which was responsible for these devices. However, we were permitted to retain the lasers to complete our study. Of note, at the time of this divestiture, ICN Pharmaceuticals Inc had no knowledge of the outcomes of this study. The project was also supported, in part, by a Dermatology Foundation Clinical Career Development Award in Dermatologic Surgery (Dr Orringer). Conflicts of interest: None identified. |
Vol 53 - N° 5
P. 775-782 - novembre 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?